Brief: GT Biopharma Reports Q1 2021 Results
18/05/2021 24:07
May 17 (Reuters) - GT Biopharma Inc GTBP.O :
* GT BIOPHARMA REPORTS FIRST QUARTER 2021 RESULTS
* Q1 LOSS PER SHARE $1.83
* AS OF MARCH 31, 2021, CASH, CASH EQUIVALENTS AND
INVESTMENTS
WERE $27.6 MILLION, COMPARED TO $5.3 MILLION AS OF DECEMBER 31,
2020
Source text for Eikon: ID:nPnkZr2Ca
Further company coverage: GTBP.O
((Reuters.Briefs@thomsonreuters.com;))